Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development

Area of Science:

• Neonatology
• Pediatric Pulmonology
• Developmental Biology

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants.
• It stems from disrupted lung development, leading to lifelong pulmonary function issues and developmental risks.
• Multifactorial contributors include pre- and postnatal factors.

Purpose of the Study:

• To review recent research on the pulmonary inflammatory response in BPD.
• To explore findings from both patient cohorts and experimental models.
• To understand factors influencing BPD pathogenesis and outcomes.

Main Methods:

• Review of recent scientific literature on BPD pathogenesis.
• Analysis of findings from human patient studies.
• Examination of data from experimental animal models.

Main Results:

• Mechanical ventilation and oxygen toxicity are central to BPD pathogenesis via pulmonary inflammation.
• The inflammatory response and its impact on alveolar and vascular growth are influenced by prenatal infections, antenatal steroids, and surfactant therapy.
• Despite research insights, recent clinical practice modifications have shown limited success in reducing BPD incidence.

Conclusions:

• Pulmonary inflammation is a critical factor in BPD development.
• While modifiable factors exist, their clinical impact on BPD incidence remains limited.
• Further research is needed to effectively combat BPD in preterm infants.